![]() |
|
|
Vol. 299, Issue 2, 528-535, November 2001
Eppley Institute, University of Nebraska Medical Center, Omaha,
Nebraska (E.G.D., B.L., W.X., L.M.S., O.L.); Department of Biochemistry
and Molecular Biology, University of Nebraska Medical Center, Omaha,
Nebraska (B.L., W.X., O.L.); and U.S. Army Medical Research Institute
of Chemical Defense, Aberdeen Proving Ground, Aberdeen, Maryland
(R.S.A., C.A.B.)
The possibility that organophosphate toxicity is due to inhibition of
targets other than acetylcholinesterase (AChE, EC 3.1.1.7) was examined
in AChE knockout mice. Mice (34-55 days old) were grouped for this
study, after it was determined that AChE, butyrylcholinesterase (BChE),
and carboxylesterase activities had reached stable values by this age.
Mice with 0, 50, or 100% AChE activity were treated subcutaneously
with the nerve agent VX. The LD50 for VX was 10 to 12 µg/kg in AChE
/
, 17 µg/kg in AChE+/
, and 24 µg/kg in AChE+/+ mice. The same cholinergic signs of toxicity were present in AChE
/
mice as in wild-type mice, even though AChE
/
mice have no AChE whose inhibition could lead to cholinergic signs. Wild-type mice, but
not AChE
/
mice, were protected by pretreatment with atropine. Tissues were extracted from VX-treated and untreated animals and tested
for AChE, BChE, and acylpeptide hydrolase activity. VX treatment
inhibited 50% of the AChE activity in brain and muscle of AChE+/+ and
+/
mice, 50% of the BChE activity in all three AChE genotypes, but
did not significantly inhibit acylpeptide hydrolase activity. It was
concluded that the toxicity of VX must be attributed to inhibition of
nonacetylcholinesterase targets in the AChE
/
mouse.
Organophosphorus ester toxicity in wild-type mice is probably due to
inhibition or binding to several proteins, only one of which is AChE.
This article has been cited by other articles:
![]() |
C. De Vriese and C. Delporte Autocrine proliferative effect of ghrelin on leukemic HL-60 and THP-1 cells J. Endocrinol., January 1, 2007; 192(1): 199 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Quistad, R. Klintenberg, and J. E. Casida Blood Acylpeptide Hydrolase Activity Is a Sensitive Marker for Exposure to Some Organophosphate Toxicants Toxicol. Sci., August 1, 2005; 86(2): 291 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. De Vriese, F. Gregoire, P. De Neef, P. Robberecht, and C. Delporte Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation Endocrinology, March 1, 2005; 146(3): 1514 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. De Vriese, F. Gregoire, R. Lema-Kisoka, M. Waelbroeck, P. Robberecht, and C. Delporte Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites Endocrinology, November 1, 2004; 145(11): 4997 - 5005. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Duysen, C. F. Bartels, and O. Lockridge Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 751 - 758. [Abstract] [Full Text] [PDF] |
||||